Voorbeelden van het gebruik van Atryn in het Engels en hun vertalingen in het Nederlands
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Patients treated with ATryn should be monitored for possible clinical immunological reactions.
Therefore it is not recommended to breastfeed whilst being treated with ATryn.
ATryn contains antithrombin alfa which is similar to the naturally occurring human antithrombin.
Until now this has not been seen in patients treated with ATryn.
Limited clinical data are available on the use of ATryn in pregnant women.
ATryn corrects the antithrombin deficiency,
In the compassionate-use programme, no blood clots were seen in the patients receiving ATryn.
Population pharmacokinetic parameters for ATryn derived from the same study revealed mean± SD.
ATryn is an anti-clotting agent and contains antithrombin alfa
ATryn is normally given with heparin another medicine that helps to prevent blood clots.
The results taken together support the effectiveness of ATryn in preventing thromboembolism in such patients.
No information on the use of ATryn in patients less than 18 years is available.
Initial treatment starts with a loading dose of ATryn targeting an antithrombin activity level of 100.
Do not use ATryn after the expiry date stated on the labelling after the letters EXP.
No antibodies to antithrombin alfa have been detected up to 90 days following treatment with ATryn.
ATryn is indicated for the prophylaxis of venous thromboembolism in surgery of patients with congenital antithrombin deficiency.
ATryn is presented as a powder for solution for infusion containing nominally 1750 IU antithrombin alfa per vial.
ATryn must not be used in people who may be hypersensitive(allergic)
Treatment with ATryn should only be started by doctors who are experienced in treating patients with congenital antithrombin deficiency.
ATryn is used in adults who have‘congenital antithrombin deficiency' inherited low levels of the protein antithrombin.